1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Christian Schmidt, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma KTE-X19, Ibrutinib - Mantle Cell Lymphoma | Phase 2 | Recruiting | Christian Schmidt, MD | 150 | 2024-02-15 | 2024-07-01 |
brexucabtagene autoleucel (1) · ibrutinib (1)
Germany (1)
Georg Hess, MD (1)